Community Program Offers Insight Into Depression and Suicide
CINCINNATIA free educational program scheduled for Saturday, April 30, will offer the community insight into depression and its role in suicide.
The event, part of a community-wide outreach strategy in connection with the launch of the Cincinnati Mood Disorders Consortium, is titled, "Depression and Suicide: What You Should Know.
The Cincinnati Mood Disorders Consortium is a collaboration of regional and international experts in mood disorders from the University of Cincinnati (UC) departments of psychiatry and behavioral neuroscience and family and community medicine, the Lindner Center of HOPE and Cincinnati Childrens Hospital Medical Center.
The event is being held from 12:30 to 5 p.m. at Xavier Universitys Cintas Center. Although it is free and open to the public, seating is limited and attendees are asked to RSVP to (877) 263-2882.
The program will feature a presentation by Eric Hipple, the former NFL quarterback who played for the Detroit Lions for 10 years. He has devoted his life to building awareness of depressive illness and to reducing stigma since the suicide of his 15-year-old son, Jeff.
A panel discussion will feature a Cincinnati couple, Karen and Dave Troup, who lost their 20-year-old son, Jake Ober, to suicide in 2010.
Formation of the Cincinnati Mood Disorders Consortium, which will be officially launched on April 29, has been a key goal of Stephen Strakowski, MD, Stanley and Mickey Kaplan Professor and Chair of Psychiatry and Behavioral Neuroscience at UC, and Paul Keck Jr., MD, CEO of the Lindner Center of HOPE. The Lindner Center of HOPE is affiliated with the UC College of Medicine, and its medical staff are part of the department of psychiatry and behavioral neuroscience.
"Our mission is to improve the lives of people with mood disorders through improved coordination of key clinical care components, research and education, says Strakowski.
Adds Keck: "Raising public awareness of mood disorders is key to our mission.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.